Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT04285736

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04285736
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04285736. Randomized; no masking; primary purpose treatment. Start 2014-12 (actual); primary completion 2016-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
Condition
NSTEMI
Intervention (Drug)
Ivabradine
Intervention (Drug)
Conventional Treatment
Lead sponsor
Cairo University (class: other)
Collaborator
National Heart Institute, Egypt (class: other government)

Record details

Record id
cardio:ct-nct04285736
Content hash
3115140c44adfecd748e140252523dc777297a981aceb37a4aa94765776377ab